Outbreak of hepatitis B in a nursing home associated with capillary blood sampling

Epidemiology and Infection

Volumn 134, Issue 5, 2006, Pages 1102-1113

  Dreesman, Johannes M ^a,d   Baillot, A ^a   Hamschmidt, L ^b   Monazahian, M ^a   Wend, U C ^c   Gerlich, W H ^c  

^a Governmental Institute of Public Health of Lower Saxony   (Germany)

^b Public Health Department   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d Niedersächsisches Landesgesundheitsamt ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEPATITIS B SURFACE ANTIGEN; VIRUS PROTEIN;

AGED; ANTIGEN DETECTION; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CAPILLARY BLOOD; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTACT EXAMINATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; EPIDEMIC; FEMALE; GENE SEQUENCE; GENERAL PRACTITIONER; GENOTYPE; GERMANY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; MALE; NUCLEOTIDE SEQUENCE; NURSING HOME; PROBABILITY; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SEROLOGY; SYMPTOM; VIREMIA; VIRUS GENOME;

AGED; AGED, 80 AND OVER; BLOOD SPECIMEN COLLECTION; CAPILLARIES; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; DNA, VIRAL; FEMALE; GERMANY; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LOGISTIC MODELS; MALE; NURSING HOMES; POLYMERASE CHAIN REACTION; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 33748357360     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806005942     Document Type: Article

References (30)

1. Webster GJ, et al. Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy. Lancet 2000; 356: 379-384.
2. Robert Koch-Institut. On the situation concerning important infectious diseases in the year 1999: Part 2: Viral hepatitis [in German]. Epidemiologisches Bulletin 2000; 28: 223-227.
3. Jursch CA, et al. Molecular approaches to validate disinfectants against hepatitis B virus. Medical Microbiology and Immunology 2002; 190: 189-197.
4. Saldanha J, et al. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001; 80: 63-71.
5. Heermann KH, et al. Quantitative determination of hepatitis B virus DNA in two international reference plasmas. Journal of Clinical Microbiology 1999; 37: 68-73.
6. Schaefer S, et al. Universal primers for real time amplification of DNA from all known orthohepadnavirus species. Journal of Clinical Virology 2003; 27: 30-37.
7. Norder H, et al. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289-309.
8. Robert Koch-Institut. On the situation concerning important infectious diseases in Germany. Viral hepatitis B and C in the year 2003 [in German]. Epidemiologisches Bulletin 2004; 37: 307-315.
9. Koppelman MH, Zaaijer HL. Diversity and origin of hepatitis B virus in Dutch blood donors. Journal of Medical Virology 2004; 73: 29-32.
10. Meisel H, et al. Transmission of hepatitis B virus two months prior to HBsAg positivity of donor blood. Transfusion Medicine and Hemotherapy 2003; 30: 228-231.
11. Uy A, et al. Genomic variability in the preS1 region and determination of transmission routes of hepatitis B virus. Journal of General Virology 1992; 73: 3005-3009.
12. Gerlich WH, et al. Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic and past hepatitis B virus infections. Journal of Clinical Microbiology 1986; 24: 288-293.
13. Love A, Stanzeit B. An epidemic of hepatitis B virus infection among intravenous drug users in Iceland. European Journal of Epidemiology 1995; 11: 397-402.
14. Hutchinson SJ, et al. Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiology and Infection 1998; 121: 185-191.
15. Stevenson J, et al. An outbreak of acute hepatitis B infection among injecting drug users in Inverclyde, Scotland. Communicable Disease and Public Health 2001; 4: 60-63.
16. Hasselhorn HM, Hofmann F. Nosocomial hepatitis B virus, hepatitis C virus and HIV infections by infectious medical personnel. Gesundheitswesen 1998; 60: 545-551.
17. Petrosillo N, et al. Molecular epidemiology of an outbreak of fulminant hepatitis B. Journal of Clinical Microbiology 2000; 38: 2975-2981.
18. CDC. Transmission of hepatitis B and C viruses in outpatient settings - New York, Oklahoma, and Nebraska, 2000-2002. Morbidity and Mortality Weekly Report 2003; 52: 901-906.
19. Hutin YJ, et al. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infection Control and Hospital Epidemiology 1999; 20: 731-735.
20. Slater PE, et al. An acupuncture-associated outbreak of hepatitis B in Jerusalem. European Journal of Epidemiology 1988; 4: 322-325.
21. Walsh B, et al. Outbreak of hepatitis B in an acupuncture clinic. Communicable Disease and Public Health 1999; 2: 137-140.
22. Hepatitis B Outbreak Investigation Team. An outbreak of hepatitis B associated with reusable subdermal electroencephalogram electrodes. Canadian Medical Association Journal 2000; 162: 1127-1131.
23. Canter J, et al. An outbreak of hepatitis B associated with jet injections in a weight reduction clinic. Archives of Internal Medicine 1990; 150: 1923-1927.
24. Douvin C, et al. An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood-sampling device. New England Journal of Medicine 1990; 322: 57-58.
25. Panknin HT. Nosocomial hepatitis B in capillary blood collection for blood sugar determination by reflectometric interpretation. Krankenpflege Journal 1993; 31: 250-252.
26. CDC. Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices - Ohio and New York City, 1996. Morbidity and Mortality Weekly Report 1997; 46: 217-221.
27. Quale JM, et al. Deja vu: Nosocomial hepatitis B virus transmission and fingerstick monitoring. American Journal of Medicine 1998; 105: 296-301.
28. De Schrijver K, Enrosurveillance Editorial Team. Hepatitis B transmission in care homes linked to blood glucose monitoring, Belgium and United States. Eurosurveillance Weekly 2005; 17 March: 10 (http://www.eurosurveillance.org/).
29. CDC. Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term care facilities, Mississippi, North Carolina, and Los Angeles county, California, 2003-2004. Morbidity and Mortality Weekly Report 2005; 54: 220-223.
30. Williams IT, et al. Viral hepatitis transmission in ambulatory health care settings. Clinical and Infectious Diseases 2004; 38: 1592-1598.